Physical interaction with human tumor-derived p53 mutants inhibits p63 activities

Sabrina Strano, Giulia Fontemaggi, Antonio Costanzo, Maria Giulia Rizzo, Olimpia Monti, Alessia Baccarini, Giannino Del Sal, Massimo Levrero, Ada Sacchi, Moshe Oren, Giovanni Blandino

Research output: Contribution to journalArticlepeer-review


The p53 tumor suppressor gene is the most frequent target for genetic alterations in human cancers, whereas the recently discovered homologues p73 and p63 are rarely mutated. We and others have previously reported that human tumor-derived p53 mutants can engage in a physical association with different isoforms of p73, inhibiting their transcriptional activity. Here, we report that human tumor-derived p53 mutants can associate in vitro and in vivo with p63 through their respective core domains. We show that the interaction with mutant p53 impairs in vitro and in vivo sequence-specific DNA binding of p63 and consequently affects its transcriptional activity. We also report that in cells carrying endogenous mutant p53, such as T47D cells, p63 is unable to recruit some of its target gene promoters. Unlike wild-type p53, the binding to specific p53 mutants markedly counteracts p63-induced growth inhibition. This effect is, at least partially, mediated by the core domain of mutant p53. Thus, inactivation of p53 family members may contribute to the biological properties of specific p53 mutants in promoting tumorigenesis and in conferring selective survival advantage to cancer cells.

Original languageEnglish
Pages (from-to)18817-18826
Number of pages10
JournalJournal of Biological Chemistry
Issue number21
Publication statusPublished - May 24 2002

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Physical interaction with human tumor-derived p53 mutants inhibits p63 activities'. Together they form a unique fingerprint.

Cite this